St Jude's Ellipse ICD gains CE mark; Taiwan device companies eye the elderly;

@FierceMedDev: Device holds promise for acid reflux. Star Tribune: Item | Follow @FierceMedDev

> St. Jude Medical ($STJ) gained a CE mark for its Ellipse implantable cardioverter defibrillator, the design of which was based on feedback from more than 200 physicians. Release

> U.S. hip and knee reconstruction demand has hit bottom, but the market hasn't resumed growth yet, according to a new Leerink Swann report. News

> Fine needle aspiration guided by CT scanning may be the best way to diagnose potentially cancerous lung nodules, according to new research. Release

> Biosensia says it will present data at this year's AACC Oak Ridge Conference in San Jose, showing how its RapiPlex diagnostic technology can be used to detect drug abuse and rapidly diagnose heart attacks. Release

> The Department of Health and Human Services proposes a one-year delay in its deadline for implementing the new ICD-10 diagnosis coding system, MedPage Today reports. Report

Biotech News

@FierceBiotech: Video games unravel drug discovery riddles. Story | Follow @FierceBiotech

@JohnCFierce: ALS patients taking D-I-Y version of experimental Neuraltus drug--sheer desperation. Via WSJ: Article. | Follow @JohnCFierce

@RyanMFierce: Takeda is backing genomic and computer analysis of psychiatric disease with Sage Bionetworks, others. News | Follow @RyanMFierce

> Merck snags rights to Endocyte's ovarian cancer drug in $1B deal. News

> Hyperion joins the growing IPO queue with $57M offering. More

> Samsung plans ambitious rollout of biosims at deep discounts. Article

Pharma News

@FiercePharma: After winning huge fines against J&J, Arkansas officials say they're not counting the money yet. Wise move. More | Follow @FiercePharma

> French market toughens up on drug prices, safety. Article

> GSK, sales rep lawyers argue OT case at Supreme Court. Item

Biotech IT News

> Pharma groups stand out in social media realm. Item

> Google VC doubles down on Big Data after biotech bets. Piece

> Amazon hungers for genomics data after NIH pact. More

> Wellcome joins chorus calling for free online access to medical research. Article

And Finally...  Medical device companies in Taiwan are increasingly developing products targeted toward the elderly because of the island's rapidly aging population. Story

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.